• Economy
  • Investing
Long Distance Investing
  • Stock
  • Editor’s Pick
Investing

SIFI TO PRESENT NEW PRODUCTS AND SCIENTIFIC DATA DURING THE 42ND CONGRESS OF THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS

by September 6, 2024
written by September 6, 2024

CATANIA, Italy, Sept. 6, 2024 /PRNewswire/ — SIFI, a leading international ophthalmic company, is pleased to announce that it will present two product innovations and new scientific data during the upcoming Congress of The European Society of Cataract and Refractive Surgeons (ESCRS) which will take place from September 6-10 in Barcelona (Spain).

“SIFI is pioneering the integration of wavefront technology with ocular surface management technologies to advance the standard of care in refractive cataract surgery. By tailoring intraocular lens optics and ocular surface treatments, our solutions allow patients to achieve superior quality of vision,” said Maria Cristina Curatolo, SIFI’s Executive Director of Innovation and Medical Science.

Two new products will be introduced:

A new version of its EVOLUX extended monofocal intraocular lens (IOL) with an improved injection technology, allowing a smoother delivery and the freedom to choose between a push or screw technique;
A new IOL calculator based on the Hoffer QST and Næser-Savini formulas, allowing a more precise calculation of spherical and cylindrical powers, also thanks to the use of artificial intelligence.

A total of five podium presentation and five e-Posters will feature clinical outcomes on SIFI’s solutions for cataract refractive surgery and ocular surface disease, such as EVOLUX, the presbyopia-correcting WELL FUSION system and the artificial tear Eyestil SYNFO. The schedule of scientific presentations is as follows:

Presented Posters on Sunday September 8th (14:15-15:45 | Room: Hall 6 & 7 – Pod 1)

Visual Performance, Subjective Satisfaction And Quality Of Life Effect Of A New Extended Monofocal Intraocular Lens (Iol) (Pagnacco C.);
Multicentric Clinical Investigation On The Use Of Preservative- Free Ophthalmic Solution Based On Sodium Hyaluronate, Osmoprotectants, And Xanthan Gum In The Treatment Of Eye Discomfort, Particularly In Dry Eye (Molero-Senosiain M.);
Visual and Refractive Outcomes after Implantation Of An Extended Monofocal Non-Diffractive Hydrophobic Intraocular Lens (Romualdi G.);
Intermediate visual acuity comparison of two non-diffractive enhanced monofocal intraocular lenses (Rotter A.).

Free Paper Session on Tuesday 10th (11:00-12:30 | Room: Free paper podium 1)

Visual Performance, Subjective Satisfaction And Quality Of Life Effect After Bilateral Implantation Of Extended Depth Of Focus Intraoular Lens (Edof IOL) Compared To Trifocal IOL: A Randomized Clinical Trial (Pagnacco C.).

On Monday September 9th (13.00-14.00 – Room 8.10) SIFI will hold a Satellite Symposium “Ultimate Vision: Mastering Sight with Wavefront Engineering and Innovative Ocular Surface Management” featuring clinical updates from Dr. G. Savini, Prof. O. Findl, Dr. K. Gabric, Prof. E. Pedrotti and Prof. R. Mencucci. 

The list of e-Posters includes:

Functional outcomes of a new enhanced monofocal IOL (Savini G. – poster ID PO323)
Long Term Visual Outcomes of an Extended Monofocal Intraocular Lens (EVOLUX® ) after Cataract Surgery (Caparas V. – poster ID PO347)
Visual Performance Of A New Advanced Monofocal Iol – Sifi Evolux (Gabrić K. – poster ID PO330)
Evaluation Of Binocular Vision And Subjective Photic Disturbances After The Implantation Of Intraocular Lenses Between The Sifi Well Fusion Edof System And Three Trifocal Iol (Physiol Finevision, Alcon Clareon Panoptix And Ast Asqelio Trifocal) (Castanera D. – poster ID PO574)
Estimated Visual Acuity And Clinical Validation For Three IOLs Based On Wavefront Engineering Technology (Vacalebre M. – poster ID PO592)

ABOUT SIFI: SIFI is a leading international ophthalmic company, headquartered in Italy, featuring an integrated business model, from research & development to manufacturing and commercialization both in pharmaceutical and biomedical sectors. Since our foundation in 1935, our mission is to improve people’s lives through meaningful innovation in eye care. SIFI exports to more than 40 countries worldwide with a direct presence in major European markets, Mexico and, through joint ventures, in China and the United Arab Emirates. More information available at www.sifigroup.com

View original content:https://www.prnewswire.co.uk/news-releases/sifi-to-present-new-products-and-scientific-data-during-the-42nd-congress-of-the-european-society-of-cataract-and-refractive-surgeons-302239875.html

Featured Image: Megapixl @ Marilyna

Disclaimer

The post SIFI TO PRESENT NEW PRODUCTS AND SCIENTIFIC DATA DURING THE 42ND CONGRESS OF THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Vail Resorts Announces Fiscal 2024 Year-End Earnings Release Date
next post
Colibri Announces Closing of First Tranche of Its Non-Brokered Private Placement and Sale of Its RC Drill Rig

You may also like

MEXC strengthens reserve backing with $390M asset increase

April 23, 2025

Oil prices rebound: what’s driving the rally and...

April 23, 2025

Silver rises with gold, but industrial demand outlook...

April 23, 2025

Lead Edge Capital founder Mitchell Green says recession...

April 23, 2025

Why is Toncoin price rising today?

April 23, 2025

BC.GAME to host ‘Untamed Arena’ during TOKEN2049 Dubai,...

April 23, 2025

Keycard launches pre-sale for Shell: the most open,...

April 23, 2025

BA stock rises as Boeing reports smaller Q1...

April 23, 2025

US stocks surge at open: Dow climbs 2.4%,...

April 23, 2025

iExec launches 1M $RLC fund to support AI...

April 23, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Fortnite applies to launch on Apple’s App Store after Epic Games court win

      May 11, 2025
    • Cargo thieves are attacking the U.S. supply chain at alarming rates

      May 10, 2025
    • Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout, pulls outlook

      May 8, 2025
    • UnitedHealthcare sued by shareholders over reaction to CEO’s killing

      May 8, 2025

    Categories

    • Economy (681)
    • Editor's Pick (348)
    • Investing (4,555)
    • Stock (820)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: Longdistanceinvestings.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 Longdistanceinvestings.com

    Long Distance Investing
    • Economy
    • Investing
    Long Distance Investing
    • Stock
    • Editor’s Pick